NCT01918449

Brief Summary

The objective of the study is to compare the results of a coordinated and interactive program for the treatment, monitoring and control of patients with a moderate-severe diagnosis of Obstructive Sleep Apnea (OSA) and treated with positive continuous pressure (CPAP), with the currently established situation. Methodology: Equivalence randomized comparative study . It will include patients with diagnosis of moderate-severe OSA (apnea-hypopnea Index \>=15) that should start treatment with (CPAP). Participating center is Hospital Santa María-Arnau de Vilanova in Lleida (Spain).These patients will be randomized to two monitoring groups (1: monitoring in the Sleep disorders unit, 2: monitoring in primary care consultations) once the OSAS diagnosis has been made and it was indicated that treatment with CPAP. Patients Will be carried out in both groups the same follow-up visits in two study arms: basal, 1 month, 3 months and 6 months. Primary outcomes: number of hours of use per day (according to the accountant of the CPAP), so that use \>= 4h/day is defined as good adherence to the treatment. Secondary outcomes: daytime sleepiness, patient satisfaction, Adverse events related to CPAP treatment. It will be collected demographic ,clinics and anthropometric variables. At the end of follow-up primary and secondary outcomes will be compared between two groups.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
210

participants targeted

Target at P75+ for not_applicable

Timeline
Completed

Started Jan 2013

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

January 1, 2013

Completed
7 months until next milestone

First Submitted

Initial submission to the registry

July 23, 2013

Completed
15 days until next milestone

First Posted

Study publicly available on registry

August 7, 2013

Completed
4 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 1, 2013

Completed
6 months until next milestone

Study Completion

Last participant's last visit for all outcomes

June 1, 2014

Completed
Last Updated

November 25, 2014

Status Verified

November 1, 2014

Enrollment Period

11 months

First QC Date

July 23, 2013

Last Update Submit

November 24, 2014

Conditions

Keywords

OSACPAP treatmentprimary careefficacy

Outcome Measures

Primary Outcomes (1)

  • Number of hours of use per day of CPAP

    Number of hours of use per day of CPAP according to the internal clock of the CPAP device

    Six month

Secondary Outcomes (8)

  • Daytime sleepiness

    At baseline and at 6 month of follow-up

  • Patient satisfaction

    Six month

  • Adverse events

    Six month

  • Quality of life

    Baseline and at 6 month of follow up

  • Cost-efficacy evaluation

    Six month

  • +3 more secondary outcomes

Other Outcomes (1)

  • Body mass index

    Six month

Study Arms (2)

Sleep Unit group

NO INTERVENTION

This group will have standard follow up in sleep unit at 1, 3 and 6 month. These patients will also be instructed in hygienic-dietary measures, standard care of cardiovascular risk factors and sleep hygiene counseling.

Primary Care group

EXPERIMENTAL

This group will have standard follow up in primary care at 1, 3 and 6 month. These patients will also be instructed in hygienic-dietary measures, standard care of cardiovascular risk factors and sleep hygiene counseling.

Other: Clinical follow up by general practitioners in primary care

Interventions

The study evaluates two different setting to follow up patients with obstructive sleep apnea on CPAP treatment

Primary Care group

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Men and women over 18 years old.
  • Patients with OSA diagnosis performed in the sleep units
  • Written informed consent signed.

You may not qualify if:

  • Previous CPAP treatment for OSA diagnosis
  • Psycho-physical inability to complete questionnaires.
  • Presence of any previously diagnosed sleep disorders: narcolepsy, insomnia, chronic sleep deprivation, regular use of hypnotic or sedative medications and restless leg syndrome
  • Patients with respiratory diseases (overlap syndrome, hypoventilation, restrictive diseases)
  • A medical history that may interfere with the study objectives or, in the opinion of the investigator, compromise the conclusions.
  • Any medical factor, social or geographical, that may jeopardize patient compliance.(e.g., alcohol consumption (more 80 gr/day in men and more than 60 gr / day in women), no fixed address, disorientation, or a history of non-compliance).

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Hospital santa Maria

Lleida, Catalonia, 25198, Spain

Location

Related Publications (1)

  • Sanchez-de-la-Torre M, Nadal N, Cortijo A, Masa JF, Duran-Cantolla J, Valls J, Serra S, Sanchez-de-la-Torre A, Gracia M, Ferrer F, Lorente I, Urgeles MC, Alonso T, Fuentes A, Armengol F, Lumbierres M, Vazquez-Polo FJ, Barbe F; Respiratory Medicine Research Group. Role of primary care in the follow-up of patients with obstructive sleep apnoea undergoing CPAP treatment: a randomised controlled trial. Thorax. 2015 Apr;70(4):346-52. doi: 10.1136/thoraxjnl-2014-206287.

MeSH Terms

Interventions

Primary Health Care

Intervention Hierarchy (Ancestors)

Comprehensive Health CarePatient Care ManagementHealth Services Administration

Study Officials

  • Ferran Barbe, MD

    Hospital Anrnau Vilanova- Santa Maria, Lleida (Spain)

    STUDY DIRECTOR
  • Cristina Esquinas, RN, MPH

    Hospital Arnau Vilanova-Santa Maria, Lleida (Spain)

    PRINCIPAL INVESTIGATOR
  • Nuria Nadal, MD

    Primary Care. National Health Institute. Lleida (Spain)

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
SUPPORTIVE CARE
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
MD

Study Record Dates

First Submitted

July 23, 2013

First Posted

August 7, 2013

Study Start

January 1, 2013

Primary Completion

December 1, 2013

Study Completion

June 1, 2014

Last Updated

November 25, 2014

Record last verified: 2014-11

Locations